Interaction between medullary and spinal δ1 and δ2 opioid receptors in the production of antinociception in the rat

Journal of Pharmacology and Experimental Therapeutics

Volumn 289, Issue 2, 1999, Pages 993-999

  Hurley, Robert W ^a   Grabow, Theodore S ^a   Tallarida, Ronald J ^b   Hammond, Donna L ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b TEMPLE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; DELTA OPIATE RECEPTOR; DELTA OPIATE RECEPTOR AGONIST; DELTORPHIN; DELTORPHIN[2 DEXTRO ALANINE 4 GLUTAMINE]; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINOCICEPTION; BLOOD BRAIN BARRIER; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFICACY; HISTOLOGY; HOT PLATE TEST; INTRACEREBRAL DRUG ADMINISTRATION; INTRATHECAL DRUG ADMINISTRATION; MALE; MEDULLA OBLONGATA; MICROINJECTION; NONHUMAN; PRIORITY JOURNAL; RAT; SPINAL CORD; TAIL FLICK TEST;

ANALGESICS, OPIOID; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; ENKEPHALIN, D-PENICILLAMINE (2,5)-; ENKEPHALINS; MALE; MEDULLA OBLONGATA; MICROINJECTIONS; OLIGOPEPTIDES; PAIN MEASUREMENT; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, DELTA; SPINAL CORD;

EID: 0032932714     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (40)

1. Bilsky EJ, Calderon SN, Wang T, Bernstein RN, Davis P, Hruby VJ, McNutt RW, Rothman RB, Rice KC and Porreca F (1995) SNC 80, a selective, nonpeptidic and systemically active opioid delta agonist. J Pharmacol Exp Ther 273:359-366.
2. Bilsky EJ, Wang T, Lai J and Porreca F (1996) Selective blockade of peripheral delta opioid agonist induced antinociception by intrathecal administration of delta receptor antisense oligodeoxynucleotide. Neurosci Lett 220:155-158.
3. Caudle RM and Williams GM (1993) The misuse of analysis of variance to detect synergy in combination drug studies. Pain 55:313-317.
4. D'Amour FE and Smith DL (1941) A method for determining loss of pain sensation. J Pharmacol Exp Ther 72:74-79.
5. Fang F and Proudfit HK (1998) Antinociception produced by microinjection of morphine in the rat periaqueductal gray is enhanced in the foot, but not the tail, by intrathecal injection of alpha1-adrenoceptor antagonists. Brain Res 790:14-24.
6. Finney DJ (1964) Statistical Method in Biological Assay. Hafner Publishing Co., New York.
7. Gebhart GF (1993) Descending modulation of spinal nociceptive processing. Der Schmerz 7:216-225.
8. Grabow T and Hammond D (1998) Noradrenergic modulation of supraspinal and spinal delta-2 opioid receptor mediated antinociceptive synergy. Anesthesiology 89:A1129.
9. Hammond DL (1993) Pharmacological mechanisms of pain modulation: An update on δ opioid receptors, in Current and Emerging Issues in Cancer Pain: Research and Practice (Chapman CR and Foley KM eds) pp 175-183, Raven Press, New York.
10. Hammond DL, Donahue BB and Stewart PE (1997) Role of spinal δ1 and δ2 opioid receptors in the antinociception produced by microinjection of L-glutamate in the ventromedial medulla of the rat. Brain Res 765:177-181.
11. Hammond DL, Stewart PE and Littell L (1995) Antinociception and delta-1 opioid receptors in the rat spinal cord: Studies with intrathecal 7-benzylidenenaltrexone. J Pharmacol Exp Ther 274:1317-1324.
12. Jensen TS and Yaksh TL II (1986) Examination of spinal monoamine receptors through which brain stem opiate-sensitive systems act in the rat. Brain Res 363:114-127.
13. 6]enkephalin and naltrindole-5′-isothiocyanate: Evidence for delta receptor subtypes. J Pharmacol Exp Ther 257:1069-1075.
14. Kamei J, Saitoh A, Ohsawa M, Suzuki T, Misawa M, Nagase H and Kasuya Y (1995) Antinociceptive effects of the selective non-peptidic delta-opioid receptor agonist TAN-67 in diabetic mice. Eur J Pharmacol 276:131-135.
15. Mattia A, Farmer SC, Takemori AE, Sultana M, Portoghese PS, Mosberg HI, Bowen WD and Porreca F (1992) Spinal opioid delta antinociception in the mouse: Mediation by a 5′-NTII-sensitive delta receptor subtype. J Pharmacol Exp Ther 260: 518-525.
16. 2]deltorphin II in mice: Evidence for delta receptor subtypes. J Pharmacol Exp Ther 258:583-587.
17. Meissler JJ Jr, Adler MW, Rogers TJ, Geller EB, Tallarida RJ and Eisenstein TK (1998) Super- and subadditive interactions of morphine and deltorphin in inducing immunosuppression. NIDA Monograph Series 178:200.
18. Miaskowski C and Levine JD (1992) Antinociception produced by receptor selective opioids: Modulation of spinal antinociceptive effects by supraspinal opioids. Brain Res 595:32-38.
19. Miaskowski C, Taiwo Y and Levine JD (1993) Antinociception produced by receptor selective opioids: Modulation of supraspinal antinociceptive effects of spinal opioids. Brain Res 608:87-94.
20. Miyamoto Y, Morita N, Kitabata Y, Yamanishi T, Kishioka S, Ozaki M and Yamamoto H (1991) Antinociceptive synergism between supraspinal and spinal sites after subcutaneous morphine evidenced by CNS morphine content. Brain Res 552:136-140.
21. Ossipov MH, Kovelowski CJ, Nichols ML, Hruby VJ and Porreca F (1995) Characterization of supraspinal antinociceptive actions of opioid delta agonists in the rat. Pain 62:287-293.
22. Porreca F and Burks T (1993) Supraspinal opioid receptors in antinociception, in Opioids II (Herz A ed) pp 21-51, Springer-Verlag, Berlin.
23. Rivlin AS and Tator CH (1977) Objective clinical assessment of motor function after experimental spinal cord injury in the rat. J Neurosurg 47:577-581.
24. Roerig SC and Fujimoto JM (1988) Morphine antinociception in different strains of mice: Relationship of supraspinal-spinal multiplicative interaction to tolerance. J Pharmacol Exp Ther 247:603-608.
25. Roerig SC and Fujimoto JM (1989) Multiplicative interaction between intrathecally and intracerebroventricularly administered mu opioid agonists but limited interactions between delta and kappa agonists for antinociception in mice. J Pharmacol Exp Ther 249:762-768.
26. 5-enkephalin in morphine-tolerant and nontolerant mice. J Pharmacol Exp Ther 257:1091-1099.
27. Siuciak J and Advokat C (1989) The synergistic effect of concurrent spinal and supraspinal opiate agonisms is reduced by both nociceptive and morphine pretreatment. Pharmacol Biochem Behav 34:265-273.
28. Sofuoglu M, Portoghese PS and Takemori AE (1991) Cross-tolerance studies in the spinal cord of β-FNA-treated mice provides further evidence for delta opioid receptor subtypes. Life Sci 49:PL153-PL156.
29. 4)deltorphin. J Pharmacol Exp Ther 266:820-828.
30. Suzuki T, Tsuji M, Mori T, Misawa M, Endoh T and Nagase H (1995) Effects of a highly selective nonpeptide δ opioid receptor agonist, TAN-67, on morphine-induced antinociception in mice. Life Sci 57:155-168.
31. 2-opioid receptors in the brain and spinal cord, respectively. Eur J Pharmacol 242:145-150.
32. Tallarida RJ (1992a) A further comment on testing for drug synergism. Pain 51: 381-382.
33. Tallarida RJ (1992b) Statistical analysis of drug combinations for synergism. Pain 49:93-97.
34. Tallarida RJ, Porreca F and Cowan R (1989) Statistical analysis of drug-drug and site-site interactions with isobolograms. Life Sci 45:947-961.
35. Thorat SN and Hammond DL (1997) Modulation of nociception by microinjection of delta-1 and delta-2 opioid receptor ligands in the ventromedial medulla of the rat. J Pharmacol Exp Ther 283:1185-1192.
36. 2-, but not δ1-, or κ-opioid receptors are involved in the tail-flick inhibition induced by β-endorphin from nucleus raphe obscurus in the pentobarbital-anesthetized rat. Eur J Pharmacol 277:251-256.
37. Woolfe G and MacDonald AD (1944) The evaluation of the analgesic action of pethidine hydrochloride (Demerol). J Pharmacol Exp Ther 80:300-307.
38. Yaksh TL and Rudy TA (1976) Chronic catheterization of the spinal subarachnoid space. Physiol Behav 17:1031-1036.
39. Yeung JC and Rudy TA (1980) Multiplicative interaction between narcotic agonisms expressed at spinal and supraspinal sites of antinociceptive action as revealed by concurrent intrathecal and intracerebroventricular injections of morphine. J Pharmacol Exp Ther 215:633-642.
40. Zaki PA, Bilsky EJ, Vanderah TW, Lai J, Evans CJ and Porreca F (1996) Opioid receptor types and subtypes: The δ opioid receptor as a model. Annu Rev Pharmacol Toxicol 36:379-401.